HQL ETF

HQL ETF
See how much of HQL you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free
Showing top 50 of 131 holdings
HQL holdings, by weight
#TickerNameWeightCumulative
1
REGN
Regeneron Pharmaceuticals Inc
7.35%
7.4%
2
AMGN
Amgen Inc
7.28%
14.6%
3
GILD
Gilead Sciences Inc
6.61%
21.2%
4
VRTX
Vertex Pharmaceuticals Inc
4.53%
25.8%
5
ALNY
Alnylam Pharmaceuticals Inc
3.45%
29.2%
6
BMRN
BioMarin Pharmaceutical Inc
3.44%
32.7%
7Neurovance Milestone Interest
3.02%
35.7%
8
GVMXX
State Street Global Advisors
2.92%
38.6%
9
INSM
Insmed Inc
2.42%
41.0%
10
ARGX
Argenx SE
2.41%
43.4%
11
BNTX
BioNTech SE
2.34%
45.8%
12
SMMT
Summit Therapeutics Inc
2.11%
47.9%
13
SRPT
Sarepta Therapeutics Inc
2.08%
50.0%
14
ASND
Ascendis Pharma A/S
1.75%
51.7%
15
NBIX
Neurocrine Biosciences Inc
1.58%
53.3%
16
AKRO
Akero Therapeutics Inc
1.58%
54.9%
17
ILMN
Illumina Inc
1.45%
56.3%
18
CYTK
Cytokinetics Inc
1.41%
57.7%
19
QURE
UniQure NV
1.35%
59.1%
20
XENE
Xenon Pharmaceuticals Inc
1.32%
60.4%
21
RARE
Ultragenyx Pharmaceutical Inc
1.31%
61.7%
22
DNLI
Denali Therapeutics Inc
1.16%
62.9%
23
IMVT
Immunovant Inc
1.13%
64.0%
24
TEM
Tempus AI Inc
1.05%
65.1%
25
RNA
Avidity Biosciences Inc
1.03%
66.1%
26
ARWR
Arrowhead Pharmaceuticals Inc
1.02%
67.1%
27
IONS
Ionis Pharmaceuticals Inc
0.98%
68.1%
28
TARS
Tarsus Pharmaceuticals Inc
0.88%
69.0%
29
AXSM
Axsome Therapeutics Inc
0.88%
69.8%
30
OCS
Oculis Holding AG
0.82%
70.7%
31
PSNL
Personalis Inc
0.77%
71.4%
32
CRNX
Crinetics Pharmaceuticals Inc
0.77%
72.2%
33
ARQT
Arcutis Biotherapeutics Inc
0.76%
73.0%
34
VIGL
Vigil Neuroscience Inc
0.75%
73.7%
35
DYN
Dyne Therapeutics Inc
0.72%
74.4%
36
PCVX
Vaxcyte Inc
0.72%
75.2%
37
ADPT
Adaptive Biotechnologies Corp
0.71%
75.9%
38
AMLX
Amylyx Pharmaceuticals Inc
0.66%
76.5%
39
EWTX
Edgewise Therapeutics Inc
0.65%
77.2%
40
IDYA
Ideaya Biosciences Inc
0.64%
77.8%
41
HALO
Halozyme Therapeutics Inc
0.64%
78.5%
42
GH
Guardant Health Inc
0.62%
79.1%
43
NUVL
Nuvalent Inc
0.61%
79.7%
44
SPRY
ARS Pharmaceuticals Inc
0.59%
80.3%
45
SION
Sionna Therapeutics Inc
0.59%
80.9%
46
TVTX
Travere Therapeutics Inc
0.58%
81.4%
47
KRYS
Krystal Biotech Inc
0.57%
82.0%
48Engrail Therapeutics Inc. Seri
0.57%
82.6%
49
ALKS
Alkermes PLC
0.56%
83.2%
50
GRAL
GRAIL Inc
0.56%
83.7%
More holdings · Pro
Not reported for this fund: shares, market value, share changes, sector, industry.
FundXLS Pro
See the other 81 holdings of HQL
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

HQL ETF All Holdings

HQL holdings total 131 positions. The top 10 holdings account for 43.4% of the fund, led by Regeneron Pharmaceuticals Inc at 7.4%, Amgen Inc at 7.3%, Gilead Sciences Inc at 6.6%.

HQL portfolio concentration is moderate, with the top 10 representing 43.4% of total assets.

HQL sectors provide a detailed breakdown. HQL overlap shows how holdings compare to other funds in your portfolio.

HQL ETF Holdings

131 of 131 holdings

  • 1

    Regeneron Pharmaceuticals Inc

    REGNUnknown
    7.35%
  • 2

    Amgen Inc

    AMGNUnknown
    7.28%
  • 3

    Gilead Sciences Inc

    GILDUnknown
    6.61%
  • 4

    Vertex Pharmaceuticals Inc

    VRTXUnknown
    4.53%
  • 5

    Alnylam Pharmaceuticals Inc

    ALNYUnknown
    3.45%
  • 6

    BioMarin Pharmaceutical Inc

    BMRNUnknown
    3.44%
  • 7

    NEUROVANCE MILESTONE INTEREST

    Unknown
    3.02%
  • 8

    State Street Global Advisors

    GVMXXUnknown
    2.92%
  • 9

    Insmed Inc

    IM8NUnknown
    2.42%
  • 10

    Argenx SE

    ARGXUnknown
    2.41%
  • 11

    BioNTech SE

    BNTXUnknown
    2.34%
  • 12

    Summit Therapeutics Inc

    SMMTUnknown
    2.11%
  • 13

    Sarepta Therapeutics Inc

    SRPTUnknown
    2.08%
  • 14

    Ascendis Pharma A/S

    ASNDUnknown
    1.75%
  • 15

    Neurocrine Biosciences Inc

    NBIXUnknown
    1.58%
  • 16

    Akero Therapeutics Inc

    AKROUnknown
    1.58%
  • 17

    Illumina Inc

    ILMNUnknown
    1.45%
  • 18

    Cytokinetics Inc

    CYTKUnknown
    1.41%
  • 19

    UniQure NV

    QUREUnknown
    1.35%
  • 20

    Xenon Pharmaceuticals Inc

    XENEUnknown
    1.32%
  • 21

    Ultragenyx Pharmaceutical Inc

    RAREUnknown
    1.31%
  • 22

    Denali Therapeutics Inc

    DNLIUnknown
    1.16%
  • 23

    Immunovant Inc

    IMVTUnknown
    1.13%
  • 24

    Tempus AI Inc

    TEMUnknown
    1.05%
  • 25

    Avidity Biosciences Inc

    RNAUnknown
    1.03%
  • 26

    Arrowhead Pharmaceuticals Inc

    ARWRUnknown
    1.02%
  • 27

    Ionis Pharmaceuticals Inc

    ISIUnknown
    0.98%
  • 28

    Tarsus Pharmaceuticals Inc

    TARSUnknown
    0.88%
  • 29

    Axsome Therapeutics Inc

    AXSMUnknown
    0.88%
  • 30

    Oculis Holding AG

    OCSUnknown
    0.82%
  • 31

    Personalis Inc

    PSNLUnknown
    0.77%
  • 32

    Crinetics Pharmaceuticals Inc

    CRNXUnknown
    0.77%
  • 33

    Arcutis Biotherapeutics Inc

    ARQTUnknown
    0.76%
  • 34

    Vigil Neuroscience Inc

    VIGLUnknown
    0.75%
  • 35

    Dyne Therapeutics Inc

    DYNUnknown
    0.72%
  • 36

    Vaxcyte Inc

    PCVXUnknown
    0.72%
  • 37

    Adaptive Biotechnologies Corp

    ADPTUnknown
    0.71%
  • 38

    Amylyx Pharmaceuticals Inc

    AMLXUnknown
    0.66%
  • 39

    Edgewise Therapeutics Inc

    EWTXUnknown
    0.65%
  • 40

    Ideaya Biosciences Inc

    IDYAUnknown
    0.64%
  • 41

    Halozyme Therapeutics Inc

    HALOUnknown
    0.64%
  • 42

    Guardant Health Inc

    GHUnknown
    0.62%
  • 43

    Nuvalent Inc

    NUVLUnknown
    0.61%
  • 44

    ARS Pharmaceuticals Inc

    SPRYUnknown
    0.59%
  • 45

    Sionna Therapeutics Inc

    SIONUnknown
    0.59%
  • 46

    Travere Therapeutics Inc

    TVTXUnknown
    0.58%
  • 47

    Krystal Biotech Inc

    KRYSUnknown
    0.57%
  • 48

    ENGRAIL THERAPEUTICS INC. SERI

    Unknown
    0.57%
  • 49

    Alkermes PLC

    ALKSUnknown
    0.56%
  • 50

    GRAIL Inc

    GRALUnknown
    0.56%
  • 51

    Ardelyx Inc

    ARDXUnknown
    0.55%
  • 52

    Geron Corp

    GONUnknown
    0.55%
  • 53

    Xencor Inc

    XNCRUnknown
    0.50%
  • 54

    Rhythm Pharmaceuticals Inc

    RYTMUnknown
    0.49%
  • 55

    ENDEAVOR BIOMEDICINES, INC.

    Unknown
    0.49%
  • 56

    Janux Therapeutics Inc

    JANXUnknown
    0.49%
  • 57

    Incyte Corp

    INCYUnknown
    0.48%
  • 58

    Medpace Holdings Inc

    MEDPUnknown
    0.47%
  • 59

    Mereo Biopharma Group PLC

    MREOUnknown
    0.46%
  • 60

    QUELL THERAPEUTICS

    Unknown
    0.44%
  • 61

    Quanterix Corp

    QTRXUnknown
    0.44%
  • 62

    Arbutus Biopharma Corp

    I9DNUnknown
    0.41%
  • 63

    Codexis Inc

    CDXSUnknown
    0.41%
  • 64

    ARBOR BIOTECHNOLOGIES

    Unknown
    0.40%
  • 65

    Incendia Therapeutics, Inc.

    Unknown
    0.40%
  • 66

    GLYCOMINE, INC.

    Unknown
    0.40%
  • 67

    QLARIS BIO, INC.

    Unknown
    0.39%
  • 68

    RECODE THERAPEUTICS

    Unknown
    0.36%
  • 69

    ATALANTA THERAPEUTICS

    Unknown
    0.35%
  • 70

    Immatics NV

    IMTXUnknown
    0.35%
  • 71

    INVETX MILESTONE INTEREST

    Unknown
    0.35%
  • 72

    Centessa Pharmaceuticals PLC

    CNTAUnknown
    0.33%
  • 73

    Merus NV

    MRUSUnknown
    0.33%
  • 74

    Vir Biotechnology Inc

    VIRUnknown
    0.33%
  • 75

    ABCURO, INC.

    Unknown
    0.32%
  • 76

    SEISMIC THERAPEUTICS, INC.

    Unknown
    0.32%
  • 77

    Korro Bio Inc

    KRROUnknown
    0.32%
  • 78

    Newamsterdam Pharma Co NV

    NAMSUnknown
    0.31%
  • 79

    Syndax Pharmaceuticals Inc

    SNDXUnknown
    0.31%
  • 80

    Immunic Inc

    IMUXUnknown
    0.29%
  • 81

    Abeona Therapeutics Inc

    ABEOUnknown
    0.27%
  • 82

    Scholar Rock Holding Corp

    SRRKUnknown
    0.27%
  • 83

    Praxis Precision Medicines Inc

    PRAXUnknown
    0.26%
  • 84

    Structure Therapeutics Inc

    GPCRUnknown
    0.24%
  • 85

    Allogene Therapeutics Inc

    ALLOUnknown
    0.22%
  • 86

    THIRD ARC BIO, INC

    Unknown
    0.21%
  • 87

    Cidara Therapeutics Inc

    CDTXUnknown
    0.20%
  • 88

    NUVIG THERAPEUTICS, INC

    Unknown
    0.20%
  • 89

    INCENDIA THERAPEUTICS, INC.

    Unknown
    0.19%
  • 90

    AMOLYT MILESTONE

    Unknown
    0.18%
  • 91

    CURASEN THERAPEUTICS, INC.

    Unknown
    0.17%
  • 92

    TScan Therapeutics Inc

    TCRXUnknown
    0.14%
  • 93

    HIBERCELL, INC. SERIES B

    Unknown
    0.14%
  • 94

    ARKUDA THERAPEUTICS,INC SER A.

    Unknown
    0.12%
  • 95

    Iovance Biotherapeutics Inc

    IOVAUnknown
    0.11%
  • 96

    EyePoint Pharmaceuticals Inc

    EYPTUnknown
    0.10%
  • 97

    ENDEAVOR BIOMEDICINES INC.

    Unknown
    0.09%
  • 98

    Tenaya Therapeutics Inc

    TNYAUnknown
    0.09%
  • 99

    HIBERCELL,INC. SERIES C

    Unknown
    0.08%
  • 100

    HOTSPOT THERAPEUTICS, INC.

    Unknown
    0.08%
  • 101

    ABCURO INC.

    Unknown
    0.08%
  • 102

    Inozyme Pharma Inc

    Unknown
    0.08%
  • 103

    BIOTHERYX, INC. SERIES E

    Unknown
    0.07%
  • 104

    Pyxis Oncology Inc

    PYXSUnknown
    0.07%
  • 105

    Rallybio Corp

    RLYBUnknown
    0.06%
  • 106

    Caribou Biosciences Inc

    CRBUUnknown
    0.06%
  • 107

    AVICEDA THERAPEUTICS

    Unknown
    0.06%
  • 108

    HIBERCELL, INC.

    Unknown
    0.05%
  • 109

    FLAMINGO THERAPEUTICS INC

    Unknown
    0.05%
  • 110

    ARKUDA THERAPEUTICS, INC.

    Unknown
    0.05%
  • 111

    Novavax Inc

    NVV1Unknown
    0.04%
  • 112

    Corbus Pharmaceuticals Holdings Inc

    CRBPUnknown
    0.04%
  • 113

    CONTRA CHINOOK THERAPE

    Unknown
    0.03%
  • 114

    Nkarta Inc

    NKTXUnknown
    0.01%
  • 115

    ALX Oncology Holdings Inc

    ALXOUnknown
    0.01%
  • 116

    Oruka Therapeutics Inc

    ORKAUnknown
    0.01%
  • 117

    I-Mab

    IMABUnknown
    0.01%
  • 118

    Mural Oncology PLC

    MURAUnknown
    0.00%
  • 119

    Arvinas Inc

    ARVNUnknown
    0.00%
  • 120

    Affimed NV

    AFMDQUnknown
    0.00%
  • 121

    CONTRA FUSION PHARMACE

    Unknown
    0.00%
  • 122

    Galera Therapeutics Inc

    GRTXUnknown
    0.00%
  • 123

    TETRAPHASE PHARMACEUTICALS INC

    Unknown
    0.00%
  • 124

    IO LIGHT HOLDINIGS, INC.

    Unknown
    0.00%
  • 125

    PRIOTHERA LIMITED

    Unknown
    0.00%
  • 126

    Willow Laboratories Inc.

    Unknown
    0.00%
  • 127

    HIBERCELL INC.

    Unknown
    0.00%
  • 128

    HIBERCELL, INC. SERIES C

    Unknown
    0.00%
  • 129

    CONTRA SPECTRUM PHARMA

    Unknown
    0.00%
  • 130

    Afferent Milestone Interest

    Unknown
    0.00%
  • 131

    Options Clearing Corp.

    Unknown
    -0.00%